Comorbidities,clinical characteristics and outcomes of COVID‑19 in pediatric patients in a tertiary medical center in the Netherlands  

作　　者：Amrita Biharie Maya WKeuning Katja CWolthers Dasja Pajkrt 

机构地区：[1]Department of Pediatric Infectious Diseases,Rheumatology and Immunology,Amsterdam University Medical Centers Location Academic Medical Center,University of Amsterdam,Meibergdreef 9,1105 AZ Amsterdam,Netherlands [2]Department of Medical Microbiology,Amsterdam University Medical Centers Location Academic Medical Center,University of Amsterdam,Amsterdam,Netherlands

出　　处：《World Journal of Pediatrics》2022年第8期558-563,共6页世界儿科杂志（英文版）

摘　　要：Having pre-existing comorbidities is described as a risk factor for more severe disease in adult corona virus disease 2019(COVID-19)and in infections with SARS-CoV-1 and MERS-CoV[1].In adult SARS-CoV-2 infections,patients with pre-existing underlying comorbidities,such as chronic obstructive pulmonary disease,cardiovascular disease,diabetes and obesity,are more likely to have severe disease compared to healthy adults[2].An inconsistency is seen in current fndings on the association with comorbidities and pediatric COVID-19 severity.An important limitation in currently available studies is limited data:severe disease is rare in children compared to adults,and most studies describe COVID-19 severity merely by reporting intensive care unit(ICU)admission or mortality rates instead of detailed data on clinical presentation and outcomes.

关 键 词：MORBID PEDIATRIC PATIENTS 

分 类 号：R726[医药卫生—儿科]